Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
22.96
+1.20 (5.51%)
Oct 6, 2025, 3:50 PM EDT - Market open
Zenas BioPharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$32.29
Upside
+40.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +30.66% | May 16, 2025 |
| Wedbush | Wedbush | Buy Initiates $35 | Buy | Initiates | $35 | +52.44% | Mar 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +95.99% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +30.66% | Mar 12, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $19 | Buy | Initiates | $19 | -17.25% | Feb 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +30.66% | Dec 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +52.44% | Dec 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Dec 3, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +17.60% | Oct 8, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +52.44% | Oct 8, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $40 | Buy | Initiates | $40 | +74.22% | Oct 8, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +95.99% | Oct 8, 2024 |